Among the survivors of Ebola virus disease (EVD), complications that include uveitis can
develop during convalescence, although the incidence and pathogenesis of EVD …

Although the first reports of successful treatment with passive immune therapy date back to
the early 1900s, convalescent plasma has materialized as a possible therapy for patients …

Ebola virus can cause severe hemorrhagic disease with high fatality rates. Currently, no
specific therapeutic agent or vaccine has been approved for treatment and prevention of …

The filoviruses, Ebola virus and Marburg virus, are zoonotic pathogens that cause severe
hemorrhagic fever in humans and nonhuman primates (NHPs), with case-fatality rates …

Rapid, reliable, and easy-to-use diagnostic assays for detection of Zaire ebolavirus (ZEBOV)
are urgently needed. The goal of this study was to examine the agreement among …

The magnitude of the 2014–2015 West African Ebola virus disease outbreak was
unforeseen at its onset and the initial international response was slow. The high mortality …

We performed a longitudinal analysis of plasma samples obtained from 4 patients with
Ebola virus (EBOV) disease (EVD) to determine the relationship between the real-time …

Objective: This report describes three patients with Ebola virus disease who were treated in
the United States and developed for severe critical illness and multiple organ failure …

Recent experimentation with the variants of the Ebola virus that differ in the glycoprotein's
poly-uridine site, which dictates the form of glycoprotein produced through a transcriptional …

Ebola Virus Disease: Experience and Decision Making for the First Patients outside of Africa |
PLOS Medicine Skip to main content Advertisement PLOS Medicine Browse Current Issue …